Stilla Technologies – Digital PCR – Naica 3 colors system
Stilla® Crystal Digital PCR™ technology for absolute quantification of nucleic acids is based on cutting-edge microfluidic technology that integrates the digital PCR process in a single consumable, reducing the hands-on time and interaction, so users can simply insert the sample and walk away.
The sample is partitioned using a network of microchannels into a large array of individual droplets, also called a droplet crystal. Owing to the next-generation Crystal Digital PCR™ technology, the droplets partitioned are identical in size- yielding results you can trust. PCR then amplifies the fluorescent target in the droplets which can be read for absolute quantification the nucleic acids.
With a combination of powerful imaging, the flexibility to use up to 3 detection channels, and a proprietary software for analysis, Crystal Digital PCR™ is designed to offer an unmatched level of confidence in the digital PCR measurement.
Key Features
Easy-to-use Solution
- On-chip integrated workflow
- Minimal hands-on time
Flexible Digital PCR
- Up to 3-color target multiplexing
- Two chip formats: from 12 to 48 samples/run
Fast Time-to-results
- Prepare (15 min), Amplify (2 hrs), Read (10-20 min), Analyze (5 min)
Featured Products
Sapphire Chip
Up to 4 samples/run Up to 30,000 droplets/sample For high sensitivity applications
Opal Chip
Up to 16 samples/run Up to 20,000 droplets/sample Desired throughput flexibility
Naica® PCR MIX Reagents
Developed for enhanced performance for Crystal Digital PCR™ on the naica® system
Geode
Thermocycler for partitioning and amplification
Prism3
Capacity: Up to 3 chips/run. Total scan time: 10min. Compatible fluorophores: FAM, Cy®3, VIC, HEX, Cy®5…
Crystal Miner Software
Intuitive software for visual inspection and analysis
The Entire Naica® System Workflow
Crystal Digital PCR™ is Stilla’s next-generation technology for absolute quantification of nucleic acids. Using cutting-edge microfluidic innovations, this technology integrates the digital PCR process in a single consumable.
Brand
At Stilla Technologies, we continuously innovate and evolve technologically toward better human health outcomes. Our global team with multidisciplinary expertise shares a passion to develop new products for advanced genetic testing and analysis. Our expertise spans from microfluidics and chemistry to molecular biology and computer science. Our product, the naica® System, has been adopted by researchers & clinicians around the world to develop a wide range of genetic tests and molecular biology assays – including, but not limited to, liquid biopsy tests for cancer diagnostics, infectious diseases, prenatal testing, and GMO detection.